Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04613492 |
| Title | A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | AstraZeneca |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Saint Louis | Missouri | 63110 | United States | Details | |
| Research Site | Buffalo | New York | 14263 | United States | Details | |
| Research Site | New York | New York | 10032 | United States | Details | |
| Research Site | New York | New York | 10065 | United States | Details | |
| Research Site | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
| Research Site | Bordeaux | 33076 | France | Details | ||
| Research Site | Toulouse | 31100 | France | Details | ||
| Research Site | Villejuif | 94800 | France | Details |